9:00 AM
 | 
Dec 13, 2018
 |  BC Extra  |  Financial News

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory Corp....

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >